Nanophase bone substitute for craniofacial load bearing application: Pilot study in the rodent
- 14 February 2017
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 106 (2) , 520-532
Abstract
An exploratory pilot study shows that a rodent mandibular defect model is useful in determining the biological response to a nanophase collagen/apatite composite designed as a biomimetic load‐bearing bone substitute. Using a critical size defect, eight groups of rats (n = 3) were implanted with four renditions of the nanophase bone substitute (NBS) biomaterial. Each rendition was tested with and without recombinant human bone morphogenetic protein 2 (BMP2). NBS biomaterial renditions were: baseline, hyper‐densified,d‐ribose crosslinked, andd‐ribose crosslinked and hyper‐densified. Biological outcomes were assessed surgically, radiologically, and histologically. With the limited power available due to the small N's involved, some interesting hypotheses were generated that will be more fully investigated in future studies. BMP2 loaded NBS, when uncrosslinked, resulted in robust bone formation in the entire defect volume (regardless of porosity). Unloaded NBS were well tolerated but did not cause significant new bone formation in the defect volume. Densification alone had little effect onin vivoperformance. Crosslinking thwarted implant uptake of BMP2 and resulted in fibrous encapsulation. It is concluded that the nanophase bone substitute is well tolerated in this bone defect model. When loaded with BMP2, implantation resulted in complete bony healing and defect closure with implant density (porosity) having little effect on bone healing or remodeling. Without BMP2 the biomaterial did not result in defect closure. Crosslinking, necessary to increase mechanical properties in an aqueous environment, disrupts osteointegration and BMP2 uptake. Alternate implant fabrication strategies will be necessary to achieve an improved balance between material strength and osteointegration. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 520–532, 2018.Keywords
This publication has 42 references indexed in Scilit:
- Nanophase bone substitute in vivo response to subcutaneous implantationJournal of Biomedical Materials Research Part A, 2012
- The role of collagen in bone strengthOsteoporosis International, 2005
- Categorical Data Analysis2002
- Implantation study of a novel hydroxyapatite/collagen (HAp/col) composite into weight‐bearing sites of dogsJournal of Biomedical Materials Research, 2002
- Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: The role of advanced glycation end productsArthritis & Rheumatism, 2001
- The biocompatibility and osteoconductive activity of a novel hydroxyapatite/collagen composite biomaterial, and its function as a carrier of rhBMP-2Journal of Biomedical Materials Research, 2000
- Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defectsJournal of Biomedical Materials Research, 1997
- Mineral phases of calcium phosphateThe Anatomical Record, 1989
- Membranous vs Endochondral Bone AutograftsJAMA Otolaryngology–Head & Neck Surgery, 1974
- Potential of ceramic materials as permanently implantable skeletal prosthesesJournal of Biomedical Materials Research, 1970